Wound Care - Angola

  • Angola
  • Revenue in the Wound Care market amounts to US$0.88m in 2024. The market is expected to grow annually by -2.13% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,052m in 2024).
  • In relation to total population figures, per person revenues of US$0.02 are generated in 2024.

Key regions: Philippines, India, Europe, United States, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Angola is experiencing steady growth due to increasing customer preferences for advanced wound care products and the presence of local special circumstances. Customer preferences in the Wound Care market in Angola are shifting towards advanced wound care products such as dressings, bandages, and wound closure devices.

This is driven by the growing awareness among customers about the benefits of these products in promoting faster wound healing and reducing the risk of infection. Customers are also seeking products that are easy to use and provide long-lasting protection. Additionally, there is a rising demand for wound care products that are suitable for different types of wounds, including chronic wounds and surgical wounds.

Trends in the market indicate a growing adoption of innovative wound care technologies in Angola. This includes the use of advanced dressings with features such as antimicrobial properties, moisture management, and wound exudate control. These technologies are designed to enhance the healing process and provide better outcomes for patients.

There is also a trend towards the use of disposable wound care products, which offer convenience and reduce the risk of cross-contamination. Furthermore, the market is witnessing an increase in the availability of wound care products through online channels, making it easier for customers to access these products. Local special circumstances in Angola contribute to the growth of the Wound Care market.

The country has a high prevalence of chronic wounds, particularly among the elderly population. This creates a significant demand for wound care products to manage and treat these wounds. Additionally, Angola has a growing healthcare infrastructure, with an increasing number of hospitals, clinics, and healthcare professionals.

This supports the demand for wound care products as healthcare providers strive to provide quality care to their patients. Underlying macroeconomic factors also play a role in the development of the Wound Care market in Angola. The country has been experiencing economic growth, which has led to an increase in disposable income and improved access to healthcare services.

This has resulted in a higher demand for healthcare products, including wound care products. Furthermore, the government of Angola has been investing in the healthcare sector, which has contributed to the growth of the market. These investments aim to improve healthcare infrastructure, enhance healthcare services, and address the healthcare needs of the population.

In conclusion, the Wound Care market in Angola is growing due to customer preferences for advanced wound care products, the presence of local special circumstances, and underlying macroeconomic factors. The market is witnessing a shift towards advanced wound care technologies, an increase in the availability of wound care products through online channels, and a growing demand for products that cater to different types of wounds. The high prevalence of chronic wounds and the expanding healthcare infrastructure in Angola further support the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)